Induced Pluripotent Stem Cells and CRISPR-Cas9 Gene-Editing on Transthyretin Amyloid Cardiomyopathy. GJSFR. 2024;24(G1):1-3. doi:10.34257/GJSFRGVOL24IS1PG1